About this trial
This prospective randomized controlled trial aims to compare the efficacy and safety of robot assisted treatment versus conventional surgery in patients with Tile B and C pelvic fractures. Eligible patients will be stratified according to Tile fracture classification and randomly assigned in a 1:1 ratio to receive either robot assisted minimally invasive fixation or conventional surgical treatment. Primary and secondary outcomes include pain relief, early mobilization, functional recovery, imaging outcomes, perioperative complications, venous thromboembolism events, laboratory parameters, opioid consumption, and healthcare resource utilization. The study aims to provide evidence for optimizing surgical treatment strategies for unstable pelvic fractures.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Diagnosis of Tile B or Tile C pelvic fracture
Injury duration less than 3 weeks
Ability to provide written informed consent
Disqualifiers
Severe open injury or skin infection at the surgical site
Hemodynamic instability preventing anesthesia or surgery
Severe psychiatric disorders or dementia
Severe obesity affecting imaging quality
Trial design
Treatments tested in this trial
- Robot Assisted Minimally Invasive Fixation
Treatment groups
Locations
Sponsors and collaborators
Junbo Liang
Lead sponsor
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
Sponsor institution